Continuous subcutaneous carbidopa improves levodopa pharmacokinetics in Parkinson's disease patients

被引：0
|
作者：
Caraco, Y.
Giladi, N.
Oren, S.
LeWitt, P. A.
机构：
来源：
MOVEMENT DISORDERS | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
349
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [1] Administration of continuous subcutaneous carbidopa improves levodopa pharmacokinetics
    Yacoby-Zeevi, O.
    Oren, S.
    LeWitt, P.
    MOVEMENT DISORDERS, 2011, 26 : S284 - S284
  • [2] Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease
    Moes, Harmen R.
    Buskens, Erik
    van Laar, Teus
    LANCET NEUROLOGY, 2024, 23 (09): : 856 - 857
  • [3] Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease Reply
    Espay, Alberto J.
    Rascol, Olivier
    LANCET NEUROLOGY, 2024, 23 (09): : 857 - 857
  • [4] Continuous levodopa/carbidopa gel therapy improves dyskinesias in Parkinson's disease
    Fox, T.
    Honig, H.
    Fox, K.
    Chauduri, R.
    Antonini, A.
    Martinez-Martin, P.
    Leimbach, S.
    Odin, P.
    MOVEMENT DISORDERS, 2009, 24 : S264 - S264
  • [5] Pharmacokinetics of levodopa/benserazide versus levodopa/carbidopa in healthy subjects and patients with Parkinson's disease
    Iwaki, Hirotaka
    Nishikawa, Noriko
    Nagai, Masahiro
    Tsujii, Tomoaki
    Yabe, Hayato
    Kubo, Madoka
    Ieiri, Ichiro
    Nomoto, Masahiro
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2015, 3 (02): : 68 - 73
  • [6] Pharmacokinetics and pharmacodynamics of levodopa/carbidopa cotherapies for Parkinson's disease
    Mueller, Thomas
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (05) : 403 - 414
  • [7] Levodopa Pharmacokinetics in Switching From Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson's Disease: A Case Report
    Nukariya, Tomonori
    Tezuka, Toshiki
    Okusa, Shohei
    Okochi, Ryotaro
    Sakai, Yuto
    Nihei, Yoshihiro
    Nakahara, Jin
    Seki, Morinobu
    JOURNAL OF MOVEMENT DISORDERS, 2025,
  • [8] Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson's disease patients
    Senek, Marina
    Nyholm, Dag
    Nielsen, Elisabet I.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (10) : 1299 - 1307
  • [9] Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
    Marina Senek
    Dag Nyholm
    Elisabet I. Nielsen
    European Journal of Clinical Pharmacology, 2018, 74 : 1299 - 1307
  • [10] Pharmacokinetics of levodopa/carbidopa prodrug (ABBV-951) 24-hour continuous subcutaneous infusion treatment for Parkinson's disease
    Rosebraugh, M.
    Kym, P.
    Liu, W.
    Facheris, M.
    Benesh, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 838 - 838
12345